XML 73 R42.htm IDEA: XBRL DOCUMENT v3.23.1
LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
May 26, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]          
Cash   $ 7,034,434 $ 17,538,272 $ 7,034,434 $ 17,538,272
Accumulated deficit   103,385,172 84,744,629 103,385,172 84,744,629
Net cash used in operating activities       $ 13,247,540 $ 14,730,742
Proceeds from issuance of common stock     $ 8,800,000    
Proceeds from issuance of debt   $ 3,000,000.0      
Stockholders equity note stock split       the Company with a face value equal to the amount paid by the Company to NanoSynex upon satisfaction of the applicable performance milestone, bearing interest at the rate of 9% per annum on the principal balance from time to time outstanding under the particular promissory note, convertible at the option of the Company into additional shares of NanoSynex in order for the Company to maintain at least a 50.1% controlling ownership interest in NanoSynex, should NanoSynex issue additional shares. The principal of the convertible notes are due and payable upon the sooner to occur of: i) five years from the date of issuance of the particular promissory note; ii) the acquisition by any person or entity of all or substantially all of the share capital of NanoSynex, through share purchase, issuance or shares or merger of NanoSynex, or the purchase of all or substantially all of the assets of NanoSynex; or iii) the initial public offering of NanoSynex.  
Nano Synex Ltd [Member]          
Restructuring Cost and Reserve [Line Items]          
Stock issued during period value acquisitions $ 1,904,989     $ 10,400,000  
Stock issued during period value new issues       $ 2,400,000